Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun Plural form of
J .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word J's.
Examples
-
J&J's Doxil—injectable drug for ovarian and other cancers
New Lapses at J&J's Doxil Supplier Peter Loftus 2011
-
The European Medicines Agency last month recommended the recall of three cancer drugs made at Ben Venue's plant, citing concerns about sterility: J&J's Velcade, Celgene's Vidaza and Pierre Fabre Medicament's Busilvex.
New Lapses at J&J's Doxil Supplier Peter Loftus 2011
-
J&J's pharmaceutical unit sales increased 9% to $5.98 billion, with Remicade gaining 15%, HIV drug Prezista up 37% and cancer drug Velcade up 20%.
J&J Profit Falls 6.3% on Deal Costs Peter Loftus 2011
-
Mahoney was named head of J&J's medical device and diagnostics group in January and led its DePuy orthopedics business before that.
Boston Scientific taps J&J executive as its next CEO Reuters 2011
-
J&J's biggest unit, medical devices and diagnostics, had sales of $6.3 billion, up 6% from a year earlier.
J&J Profit Falls 6.3% on Deal Costs Peter Loftus 2011
-
The sluggish economy and pricing pressure from health payers have damped sales growth for certain businesses, while manufacturing-quality lapses have led to a series of product recalls, mostly in J&J's over-the-counter medicine business.
J&J Profit Falls 6.3% on Deal Costs Peter Loftus 2011
-
Thanks for reading, and goodniight from all of us.11.32pm: Brian– Paul McCartney: LL Cool J's homie.
-
Joshua: LL Cool J's mournful opening speaks to how much of an overhaul this show has gotten overnight, with a more serious and revenential tone –at least for the opening.
-
J&J's consumer unit sales rose 5% to $3.74 billion, helped by baby-care, skin-care and oral-care products.
J&J Profit Falls 6.3% on Deal Costs Peter Loftus 2011
-
Mahoney, 46, who has served as chairman of J&J's medical device and diagnostics business, will become Boston Scientific's president on October 17 and is expected to become CEO next year on Nov 1, 2012, to accommodate post-employment obligations with J&J, Boston Scientific said.
Boston Scientific taps J&J executive as its next CEO Reuters 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.